earnings

Alcon Beats Expectations Since its Split from Novartis
Alcon Beats Expectations Since its Split from Novartis
Medical Devices and Diagnostics Industry
Alcon
earnings
Novartis
eye health
Flag link:
Dr. Reddy's (RDY) to Report Q4 Earnings: What's in Store?
Dr. Reddy's (RDY) to Report Q4 Earnings: What's in Store?
Yahoo/Zacks.com
Dr Reddy's
earnings
Flag link:
3 Key Takeaways From Portola Pharmaceuticals' Quarterly Results
3 Key Takeaways From Portola Pharmaceuticals' Quarterly Results
Motley Fool
Portola Pharmaceuticals
earnings
Factor Xa inhibition
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
biotech
Achillion
Sesen Bio
The Medicines Company
Amgen
Daiichi Sankyo
earnings
Flag link:
Novo Nordisk Trots Along Waiting for Its Next-Generation Oral Drug
Novo Nordisk Trots Along Waiting for Its Next-Generation Oral Drug
Motley Fool
Novo Nordisk
earnings
diabetes
oral semaglutide
FDA
Flag link:
Jazz Pharmaceuticals Hits All the Right Notes in Q1
Jazz Pharmaceuticals Hits All the Right Notes in Q1
Motley Fool
Jazz Pharmaceuticals
earnings
Flag link:
bluebird bio Flies Forward
bluebird bio Flies Forward
Motley Fool
Bluebird Bio
earnings
Flag link:
Mylan's Struggles Continue in the First Quarter
Mylan's Struggles Continue in the First Quarter
Motley Fool
Mylan Labs
earnings
Flag link:
What's Behind Regeneron's Q1 Revenue and Earnings Misses
What's Behind Regeneron's Q1 Revenue and Earnings Misses
Motley Fool
Regeneron Pharmaceuticals
earnings
Flag link:
Bausch Health Companies Posts Strongest Organic Growth in 3 Years
Bausch Health Companies Posts Strongest Organic Growth in 3 Years
Motley Fool
Bausch Health
earnings
Flag link:
Has Gilead Sciences Turned the Corner?
Has Gilead Sciences Turned the Corner?
Motley Fool
Gilead Sciences
earnings
Flag link:
Pacira BioSciences Rocks in Q1 With Strong Momentum for Pain Drug Exparel
Pacira BioSciences Rocks in Q1 With Strong Momentum for Pain Drug Exparel
Motley Fool
Pacira
earnings
Flag link:
Cost cuts to the rescue for Teva, so far
Cost cuts to the rescue for Teva, so far
BioPharma Dive
Teva Pharmaceutical
earnings
Flag link:
Alnylam posts strong Onpattro sales as competition heats up
Alnylam posts strong Onpattro sales as competition heats up
Biopharma Dive
Alnylam
Onpattro
earnings
Flag link:
Gilead stock ticks higher as earnings beat Street, revenue doesn't
Gilead stock ticks higher as earnings beat Street, revenue doesn't
Marketwatch
Gilead Sciences
earnings
Flag link:
Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses
Glaxo (GSK) Beats on Q1 Earnings & Sales, Shingrix Impresses
Yahoo/Zacks.com
GSK
earnings
Shingrix
Flag link:
BioMarin Isn't a "Gene Therapy Company"
BioMarin Isn't a "Gene Therapy Company"
Motley Fool
Biomarin
earnings
Flag link:
3 Things You Can Expect in Gilead Sciences' Q1 Earnings Update
3 Things You Can Expect in Gilead Sciences' Q1 Earnings Update
Motley Fool
Gilead Sciences
earnings
Flag link:
Key drugs Repatha, Aimovig flail as cheap copies eat into Amgen sales
Key drugs Repatha, Aimovig flail as cheap copies eat into Amgen sales
Fierce Pharma
Amgen
earnings
Flag link:
Seattle Genetics' "Growth Is Tracking Well"
Seattle Genetics' "Growth Is Tracking Well"
Motley Fool
Seattle Genetics
earnings
Flag link:

Pages